Stuart Ungar is listed as a director on 5 SEC Form D filings by 1 issuer between Sep 2015 and Sep 2022: Akari Therapeutics Plc (Tampa, FL — other health care — 2015–2022; $75M reported sold to 62 investors).
What this means One deal on file with the SEC. A Form D is the notice a company files after it starts selling a private investment — it is a notice, not an approval.
Listed alongside James Hill (5 shared filings), Ray Prudo (5 shared filings), Clive Richardson (4 shared filings), David Byrne (4 shared filings), Donald Williams (4 shared filings) and 10 others.
What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Stuart. Each name links to their own page.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AK, AL, AR, AZ, CA, CT, DE, FINRA, GA, HI, ID, IL, KS, KY, LA, MA, MD, ME, MI, MO, MS, MT, NASAA, NC, ND, NH, NM, NV, OK, OR, PA, RI, SC, SD, TN, TX, VT, WA, WI, WV, WY) — none found.
What this means Nothing turned up where we looked (3 sources). That does not prove there is nothing — it means none was found in those sources on that date.
We compared 5 public filings for Stuart Ungar and found 1 difference: Form D filed 27 days after the first sale.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.